(Q36431150)

English

Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 August 2017

Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy (English)

1 reference

Europe PubMed Central

14 August 2017

1 reference

based on heuristic

inferred from title

author name string

K T Kelsey

1

1 reference

Europe PubMed Central

14 August 2017

D Ross

2

1 reference

Europe PubMed Central

14 August 2017

R D Traver

3

1 reference

Europe PubMed Central

14 August 2017

D C Christiani

4

1 reference

Europe PubMed Central

14 August 2017

Z F Zuo

5

1 reference

Europe PubMed Central

14 August 2017

M R Spitz

6

1 reference

Europe PubMed Central

14 August 2017

M Wang

7

1 reference

Europe PubMed Central

14 August 2017

X Xu

8

1 reference

Europe PubMed Central

14 August 2017

B K Lee

9

1 reference

Europe PubMed Central

14 August 2017

B S Schwartz

10

1 reference

Europe PubMed Central

14 August 2017

J K Wiencke

11

1 reference

Europe PubMed Central

14 August 2017

language of work or name

0 references

publication date

1 January 1997

1 reference

Europe PubMed Central

14 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

14 August 2017

76

1 reference

Europe PubMed Central

14 August 2017

852-854

1 reference

Europe PubMed Central

14 August 2017

7

1 reference

Europe PubMed Central

14 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1997.474

0 references

Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228056

30 September 2017

Cancer in Hispanics: issues of concern.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228056

30 September 2017

DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228056

30 September 2017

Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228056

30 September 2017

Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228056

30 September 2017

NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228056

30 September 2017

Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228056

30 September 2017

Response to treatment of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228056

30 September 2017

DT-diaphorase and cancer chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228056

30 September 2017

A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228056

28 June 2018

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228056

28 June 2018

The Role of NAD(P)H: Quinone Reductase (EC 1.6.99.2, DT-Diaphorase) in the Reductive Bioactivation of the Novel Indoloquinone Antitumor Agent E09

1 reference

https://pubmed.ncbi.nlm.nih.gov/9328142

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary leukaemia after MMM combined modality therapy for breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9328142

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Re: Detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9328142

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1997.474

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36431150&oldid=1630557581"